Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / October / Heidelberg and NetraMind Bring AI Power to Retinal Imaging
Retina Research & Innovations

Heidelberg and NetraMind Bring AI Power to Retinal Imaging

10/22/2025 3 min read

Share

Deeper insights into choroidal health with AI-powered analysis Heidelberg Engineering has announced a new collaboration with NetraMind Innovations, Inc., an AI-driven image analysis software company founded by leading retinal specialists and machine learning engineers. Their new application, NMI-ChoroidAI*, is now available via the Heidelberg AppWay marketplace. NMI-ChoroidAI leverages advanced machine learning to intelligently process SPECTRALIS® OCT volume data, automatically segmenting the inner and outer choroidal boundaries and analyzing choroidal vasculature. This enables precise 3D segmentation and provides comprehensive measurements of choroidal thickness, volume, and the Choroidal Vascularity Index (CVI). Results are delivered in ETDRS grid format and detailed tabulated reports, designed for seamless integration into both clinical workflows and research protocols. Dr. Jay Chhablani, Professor of Ophthalmology at the University of Pittsburgh and Director of the Choroidal Analysis and Research Lab at UPMC Eye Center, explained: “Accurate assessment of the choroid is essential in understanding and managing retinal diseases such as AMD, CSCR, and pathological myopia. Manual segmentation is often time-consuming and subjective. With NMI-ChoroidAI, clinicians and researchers gain objective, reproducible, and fully automated analyses in a fraction of the time, enhancing both patient care and scientific discovery.

Dr. Jay Chhablani

He added, “With NMI-ChoroidAI on the Heidelberg AppWay platform, ophthalmologists and researchers can now unlock deeper insights into the choroid, helping to improve diagnostic confidence, streamline workflow, and accelerate research into ocular diseases."

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: